Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
2,225 USD | +4,46% | +4,41% | -33,04% |
Métier
Nombre d'employés: 330
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Cell and Gene Therapies
100,0
%
| 130 | 100,0 % | 65 | 100,0 % | -50,42% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 130 | 100,0 % | 65 | 100,0 % | -50,42% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Kristin Yarema
CEO | Chief Executive Officer | 53 | 01/04/23 |
Johanna Mylet
DFI | Director of Finance/CFO | 37 | 01/06/15 |
Mark Gergen
CHM | Chairman | 61 | 01/02/18 |
Loren Wagner
COO | Chief Operating Officer | - | 01/03/21 |
Chief Tech/Sci/R&D Officer | - | - | |
Kristin Martin
ADM | Chief Administrative Officer | 49 | 01/01/19 |
Harry Leonhardt
CMP | Compliance Officer | 67 | 16/07/20 |
Sarah Thailing
IRO | Public Communications Contact | - | 01/11/20 |
Lisa Portale
LAW | General Counsel | - | 01/01/19 |
Karen Basbaum
PRN | Corporate Officer/Principal | - | 01/07/20 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Marcea Lloyd
BRD | Director/Board Member | 75 | 01/01/19 |
Cynthia Collins
BRD | Director/Board Member | 65 | 23/07/21 |
Mark Gergen
CHM | Chairman | 61 | 01/02/18 |
John Schmid
BRD | Director/Board Member | 60 | 19/07/18 |
Charles Baum
BRD | Director/Board Member | 65 | 16/05/22 |
Rafael Amado
BRD | Director/Board Member | 60 | 13/04/23 |
Kristin Yarema
CEO | Chief Executive Officer | 53 | 01/04/23 |
Luke Corning
BRD | Director/Board Member | 41 | 16/12/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 96 489 127 | 63 182 205 ( 65,48 %) | 0 | 65,48 % |
Coordonnées société
Poseida Therapeutics, Inc.
9390 Towne Centre Drive Suite 200
92121, San Diego
+858 779 3100
http://www.poseida.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-33,04% | 206 M | |
-2,58% | 103 Md | |
+1,37% | 95,28 Md | |
+1,75% | 22,15 Md | |
-15,67% | 21,02 Md | |
-8,19% | 18,15 Md | |
-41,01% | 16,73 Md | |
-13,43% | 16,05 Md | |
+4,13% | 13,68 Md | |
+34,55% | 12,17 Md |
- Bourse
- Actions
- Action PSTX
- Société Poseida Therapeutics, Inc.